AxoTect Overview
- Year Founded
-
2005
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
AxoTect General Information
Description
Developer of calpain inhibitors designed to offer treatment for cancer related neuropathies. The company's calpain inhibitors are engaged in developing drugs for treating chemotherapy-induced peripheral neuropathy and other neurological disorders, enabling cancer patients to get advanced treatment for their diseases.
Contact Information
Corporate Office
- 1180 West Peachtree Street, North West
- Suite 1450
- Atlanta, GA 30309
- United States
Corporate Office
- 1180 West Peachtree Street, North West
- Suite 1450
- Atlanta, GA 30309
- United States
AxoTect Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 31-Dec-2015 | Completed | Out of Business | |||
| 4. Grant | 01-Jan-2010 | Completed | Startup | |||
| 3. Grant | 01-Jan-2009 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Early Stage VC | 01-Jan-2005 | Completed | Startup |
AxoTect FAQs
-
When was AxoTect founded?
AxoTect was founded in 2005.
-
Where is AxoTect headquartered?
AxoTect is headquartered in Atlanta, GA.
-
What industry is AxoTect in?
AxoTect’s primary industry is Drug Discovery.
-
Is AxoTect a private or public company?
AxoTect is a Private company.
-
What is AxoTect’s current revenue?
The current revenue for AxoTect is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process